Cargando…

Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country

Since smoking accounts for around 30% of all cancer deaths, public health campaigns often focus on smoking cessation as a means of primary prevention. However, smoking after cancer diagnosis is also associated with a higher symptom burden and lower survival rate. As data regarding smoking cessation...

Descripción completa

Detalles Bibliográficos
Autores principales: Golčić, Marin, Tomaš, Ilijan, Stevanović, Aleksandra, Golčić, Goran, Dobrila-Dintinjana, Renata, Erić, Suzana, Šambić-Penc, Mirela, Baretić Marinac, Martina, Gović-Golčić, Lidija, Majnarić, Tea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395437/
https://www.ncbi.nlm.nih.gov/pubmed/34449569
http://dx.doi.org/10.3390/clinpract11030067
_version_ 1783744172204752896
author Golčić, Marin
Tomaš, Ilijan
Stevanović, Aleksandra
Golčić, Goran
Dobrila-Dintinjana, Renata
Erić, Suzana
Šambić-Penc, Mirela
Baretić Marinac, Martina
Gović-Golčić, Lidija
Majnarić, Tea
author_facet Golčić, Marin
Tomaš, Ilijan
Stevanović, Aleksandra
Golčić, Goran
Dobrila-Dintinjana, Renata
Erić, Suzana
Šambić-Penc, Mirela
Baretić Marinac, Martina
Gović-Golčić, Lidija
Majnarić, Tea
author_sort Golčić, Marin
collection PubMed
description Since smoking accounts for around 30% of all cancer deaths, public health campaigns often focus on smoking cessation as a means of primary prevention. However, smoking after cancer diagnosis is also associated with a higher symptom burden and lower survival rate. As data regarding smoking cessation vary dramatically between different populations, we aimed to analyze smoking prevalence in cancer patients, smoking cessation after cancer diagnosis, and the factors associated with smoking cessation in the setting of a developing country. We performed a cross-sectional survey on 695 patients in two clinical hospital centers. After cancer diagnosis, 15.6% of cancer patients stopped smoking. Male gender, younger age, and smoking-related cancer were the main factors associated with greater smoking cessation (p < 0.05). A total of 96% of breast cancer patients continued to smoke after cancer diagnosis and, compared to lung and colorectal cancer patients, exhibited a lower reduction in the number of cigarettes smoked (p = 0.023). An alarming rate of smoking prevalence was recorded in younger patients (45.6% at the time of cancer diagnosis) suggesting a future rise in smoking-related cancers and complications. These results should guide anti-smoking public health campaigns in transitional countries with a critical focus on younger and breast cancer patients.
format Online
Article
Text
id pubmed-8395437
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83954372021-08-28 Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country Golčić, Marin Tomaš, Ilijan Stevanović, Aleksandra Golčić, Goran Dobrila-Dintinjana, Renata Erić, Suzana Šambić-Penc, Mirela Baretić Marinac, Martina Gović-Golčić, Lidija Majnarić, Tea Clin Pract Article Since smoking accounts for around 30% of all cancer deaths, public health campaigns often focus on smoking cessation as a means of primary prevention. However, smoking after cancer diagnosis is also associated with a higher symptom burden and lower survival rate. As data regarding smoking cessation vary dramatically between different populations, we aimed to analyze smoking prevalence in cancer patients, smoking cessation after cancer diagnosis, and the factors associated with smoking cessation in the setting of a developing country. We performed a cross-sectional survey on 695 patients in two clinical hospital centers. After cancer diagnosis, 15.6% of cancer patients stopped smoking. Male gender, younger age, and smoking-related cancer were the main factors associated with greater smoking cessation (p < 0.05). A total of 96% of breast cancer patients continued to smoke after cancer diagnosis and, compared to lung and colorectal cancer patients, exhibited a lower reduction in the number of cigarettes smoked (p = 0.023). An alarming rate of smoking prevalence was recorded in younger patients (45.6% at the time of cancer diagnosis) suggesting a future rise in smoking-related cancers and complications. These results should guide anti-smoking public health campaigns in transitional countries with a critical focus on younger and breast cancer patients. MDPI 2021-08-10 /pmc/articles/PMC8395437/ /pubmed/34449569 http://dx.doi.org/10.3390/clinpract11030067 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Golčić, Marin
Tomaš, Ilijan
Stevanović, Aleksandra
Golčić, Goran
Dobrila-Dintinjana, Renata
Erić, Suzana
Šambić-Penc, Mirela
Baretić Marinac, Martina
Gović-Golčić, Lidija
Majnarić, Tea
Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country
title Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country
title_full Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country
title_fullStr Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country
title_full_unstemmed Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country
title_short Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country
title_sort smoking cessation after a cancer diagnosis: a cross-sectional analysis in the setting of a developing country
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395437/
https://www.ncbi.nlm.nih.gov/pubmed/34449569
http://dx.doi.org/10.3390/clinpract11030067
work_keys_str_mv AT golcicmarin smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT tomasilijan smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT stevanovicaleksandra smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT golcicgoran smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT dobriladintinjanarenata smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT ericsuzana smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT sambicpencmirela smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT bareticmarinacmartina smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT govicgolciclidija smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry
AT majnarictea smokingcessationafteracancerdiagnosisacrosssectionalanalysisinthesettingofadevelopingcountry